FDA Inspection 1148558 — Laboratorio Banco Vida

Laboratorio Banco Vida — FEI 3015767533

The FDA completed an inspection of Laboratorio Banco Vida on August 12, 2021 in San Juan, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 12, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Juan, PR (United States)

Citations

IDCFRDescription
1232521 CFR 1271.160(b)(6)Deviations--evaluation, cause, corrective action
1233621 CFR 1271.180(a)Procedures to meet core CTGP
1240121 CFR 1271.230(b)Reduced risk representation